Anticoagulation in ICH Survivors for Stroke Prevention and Recovery (NCT03907046)
Anticoagulation in Intracerebral Hemorrhage (ICH) Survivors for Stroke Prevention and Recovery
🩺 Plain-English Summary (8th-Grade Level)
Primary Aim: To determine if apixaban is superior to aspirin for prevention of the composite outcome of any stroke (hemorrhagic or ischemic) or death from any cause in patients with recent ICH and atrial fibrillation (AF). Secondary Aim: To determine if apixaban, compared with aspirin, results in better functional outcomes as measured by the modified Rankin Scale.
Who can join: Review the eligibility criteria below.
Location: University of Alabama Hospital — Birmingham, Alabama
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (187 Sites)
Showing the first 25 of 187 sites.
- University of Alabama Hospital — Birmingham, Alabama
- University of South Alabama University Hospital — Mobile, Alabama
- Chandler Regional Medical Center — Chandler, Arizona
- St. Joseph's Hospital and Medical Center — Phoenix, Arizona
- Banner University Medical Center — Tucson, Arizona
- UAMS Medical Center — Little Rock, Arkansas
- Mercy San Juan Medical Center — Carmichael, California
- Eden Medical Center, Castro Valley — Castro Valley, California
- Arrowhead Regional Medical Center — Colton, California
- Rancho Los Amigos National Rehabilitation Center — Downey, California
- Kaiser Permanente Fontana Medical Center — Fontana, California
- Community Regional Medical Center of Fresno — Fresno, California
- St. Jude Medical Center — Fullerton, California
- Long Beach Memorial Medical Center — Long Beach, California
- Los Alamitos Medical Center — Los Alamitos, California
- Kaiser Permanente Los Angeles Medical Center — Los Angeles, California
- Cedars-Sinai Medical Center — Los Angeles, California
- Ronald Reagan UCLA Medical Center — Los Angeles, California
- Doctors Medical Center Modesto, Modesto, CA — Modesto, California
- Hoag Hospital Newport Beach — Newport Beach, California
- UC Irvine Medical Center — Orange, California
- Desert Regional Medical Center — Palm Springs, California
- Huntington Memorial Hospital — Pasadena, California
- Kaiser Permanente Redwood City Medical Center, Redwood City, CA — Redwood City, California
- UC Davis Medical Center — Sacramento, California
📞 Contact the Study Coordinator
Phone: (443) 615-4729
Email: kevin.sheth@yale.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Intracerebral Hemorrhage
- ROSE-Longitudinal Assessment With Neuroimaging — Chicago, Illinois
- Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial — Birmingham, Alabama
- Regulating Blood Pressure During Recovery From Intracerebral Hemorrhage and Ischemic Stroke — New Haven, Connecticut
- Biomarker and Edema Attenuation in IntraCerebral Hemorrhage (BEACH) — Birmingham, Alabama
- Synergistic Minimally Invasive Surgery and Deferoxamine in ICH — Chicago, Illinois
- Auricular VNS Following Intracerebral Hemorrhage — St Louis, Missouri
Explore by condition: All Intracerebral Hemorrhage clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.